GSTP1 CpG island hypermethylation for DNA-based detection of occult tumor cells in surgical margins after radical prostatectomy

World Journal of Urology

Volumn 30, Issue 4, 2012, Pages 541-546

  Jentzmik, Florian ^a   Krause, Hans ^b   Reichelt, Ute ^b   Schrader, Andres Jan ^a   Schrader, Mark ^a   Baumunk, Daniel ^b   Cash, Hannes ^b   Miller, Kurt ^b   Schostak, Martin ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

GSTP1; Prostate cancer; Radical prostatectomy; Surgical margin

Indexed keywords

EID: 84864544593     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0764-2     Document Type: Article

References (20)

1. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT (1998) A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90: 766-771.
2. Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT (2008) Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 179: 47-51.
3. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinical localized prostate cancer. J Urol 169: 517-523.
4. Bolla M, Poppel H, Collette L, Cangh P, Vekemans K, Da Pozzo L, Reijke TM, Verbaeys A, Bosset JF, Velthoven R, Maréchal JM, Scalliet P, Haustermans K, Piérart M (2005) Postoperative radiotherapy after radical prostatectomy: a randomised controlled trail (EORTC trail 22911). Lancet 366: 572-578.
5. Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate cancer. N Engl J Med 349: 366-381.
6. Goessl C, Müller M, Heicappell R, Krause H, Miller K (2001) DNA-based detection of prostate cancer in blood, urine, and ejaculates. Ann NY Acad Sci 945: 51-58.
7. Köllermann J, Müller M, Goessl C, Krause H, Helpap B, Pantel K, Miller K (2003) Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patients. Eur Urol 44: 533-538.
8. Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG (2005) Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin Cancer Res 11(11).
9. Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG (2004) GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J Cell Biochem 91: 540-552.
10. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG (2006) Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 98(4): 255-261.
11. McNeal JE (1969) Origin and development of carcinoma of the prostate. Cancer 23: 24.
12. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P (2000) Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89(8): 1800-1809.
13. Jeronimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG, Sidransky D (2001) Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 93: 1747-1752.
14. Straub B, Müller M, Krause H, Goessl C, Schrader M, Heicappell R, Miller K (2001) Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomy. Urol 57: 1006-1011.
15. Theodorescu D, Frierson HF, Sikes RA (1999) Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. J Urol 161: 1442-1448.
16. Nakayama M, Bennett CJ, Hicks JL, Epstein JI, Platz EA, Nelson WG, De Marzo AM (2003) Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplasitc epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 163: 923-933.
17. Bastian PJ, Yegnasubramanian S, Palapattu GS, Rogers CG, Lin X, De Marzo AM, Nelson WG (2004) Molecular biomarker in prostate cancer: the role of CpG island hypermethylation. Eur Urol 46: 698-708.
18. Harden SV, Sanderson H, Goodman SN, Partin AA, Walsh PC, Epstein JI, Sidransky D (2003) Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies. J Natl Cancer Inst 95: 1634-1637.
19. Henrique R, Jeronimo C (2004) Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol 46: 660-669.
20. Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Müller SC, von Rücker A (2007) Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB and other gene loci in patients undergoing radical prostatectomy. Eur Urol 51: 665-674.